ViewRay

ViewRay, Inc. designs, manufactures and markets magnetic resonance imaging (MRI) system. It develops MRIdian to address the limitations of existing external-beam radiation therapy technologies, and employs MRI-based technology to provide real-time imaging that defines the tumor from the surrounding soft tissue, and other critical organs, both before and during radiation treatment delivery. The company was founded by Dinara Akzhigitova in 2004 and is headquartered in Oakwood Village, OH.

Earnings data Q1 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

ViewRay, Inc. designs, manufactures, and markets the MRIdian MRI-guided Radiation Therapy System. It develops MRIdian to address the limitations of existing external-beam radiation therapy technologies and employs MRI-based technology to provide real-time imaging that defines the tumor from the surrounding soft tissue, and other critical organs, both before and during radiation treatment delivery. The company was founded by Dinara Akzhigitova in 2004 and is headquartered in Oakwood Village, OH.

Investors need to pay close attention to ViewRay (VRAY) stock based on the movements in the options market lately.

Are Options Traders Betting on a Big Move in ViewRay (VRAY) Stock?

It was a perfect storm of problems for the medical-equipment manufacturer.

Why ViewRay Stock Fell 56% in August

Shares continue to rebound after an SEC filing reveals that an insider has been quietly adding to his position.

Here's Why ViewRay Stock Is Surging Again

COO of Viewray Inc (30-Year Financial, Insider Trades) Shahriar Matin (insider trades) bought 60,000 shares of VRAY on 08/14/2019 at an average price of $4.02 a share.

Viewray Inc (VRAY) COO Shahriar Matin Bought $241,200 of Shares

President & CEO of Viewray Inc (30-Year Financial, Insider Trades) Scott William Drake (insider trades) bought 131,260 shares of VRAY on 08/13/2019 at an average price of $3.81 a share.

Viewray Inc (VRAY) President & CEO Scott William Drake Bought $500,101 of Shares

GTT Communications

Roku

Momentum carried one of these stocks higher, while two others bounced back from tough hits recently.

Why Roku, GTT Communications, and ViewRay Jumped Today

Is the Options Market Predicting a Spike in ViewRay (VRAY) Stock?

Shares start to rebound after a gut-wrenching decline.

Why ViewRay Stock Is Bouncing Back Today

Traders are fleeing after the company reports mixed second-quarter results and slashes full-year guidance.

Why ViewRay Stock Is Being Mauled Today

ViewRay, Inc. (VRAY) CEO Scott Drake on Q2 2019 Results - Earnings Call Transcript

ViewRay, Inc. (VRAY) CEO Scott Drake on Q1 2019 Results - Earnings Call Transcript

First-quarter results missed the mark, but traders are feeling upbeat because this company's backlog continues to grow.

Here's Why ViewRay Is on the Upswing Today

ViewRay (VRAY) delivered earnings and revenue surprises of -54.55% and -3.30%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

ViewRay (VRAY) Reports Q1 Loss, Lags Revenue Estimates

In the latest trading session, ViewRay (VRAY) closed at $7.72, marking a -0.13% move from the previous day.

ViewRay (VRAY) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, ViewRay (VRAY) closed at $8.37, marking a -1.59% move from the previous day.

ViewRay (VRAY) Stock Moves -1.59%: What You Should Know

ViewRay, Inc. (VRAY) CEO Scott Drake on Q4 2018 Results - Earnings Call Transcript

News for ViewRay Stock (VRAY)